Financhill
Back

Orgenesis Stock Predictions

Orgenesis Stock Forecast

  • Is Orgenesis Stock Undervalued?
    The current Orgenesis [ORGS] share price is $1.23. The Score for ORGS is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
  • ORGS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Orgenesis Stock Go Up Next Year?

Data Unavailable

Orgenesis Stock Rating

Data Unavailable

Orgenesis Stock Price History

Is ORGS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORGS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
orgenesis.com

52-Week Data

52-Week High:
10.80
52-Week Low:
1.03

Prediction Charts

Market Cap:
5.84M
Price in USD:
1.23
Volume:
15.92K
Beta:
5.45

Technical Analysis

SMA50:
4.67
SMA100:
5.66
SMA200:
5.52
52-Wk Change:
-84.88%

Stock Predictions

  • Is Orgenesis stock public?
    Yes, Orgenesis is a publicly traded company.
  • What is the Orgenesis stock quote today?
    The Orgenesis stock price is 1.23 USD today.
  • How to buy Orgenesis stock online?
    You can buy Orgenesis shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-10 3.80 3.82 3.95 3.80
Oct-11 3.80 3.75 3.90 3.72
Oct-14 3.69 3.26 3.71 3.03
Oct-15 3.15 2.88 3.20 2.81
Oct-16 2.85 3.39 3.49 2.76
Oct-18 1.95 2.11 2.37 1.93
Oct-21 2.02 1.53 2.05 1.42
Oct-22 1.53 1.22 1.55 1.10
Oct-23 1.15 1.15 1.19 1.03
Oct-24 1.15 1.19 1.19 1.13
Oct-25 1.13 1.20 1.31 1.13
Oct-28 1.30 1.23 1.35 1.21
Oct-29 1.25 1.17 1.29 1.12
Oct-30 1.25 1.23 1.27 1.12

Orgenesis Earnings

Data Unavailable

Orgenesis Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and a decrease next year of $0.00 per share.

* Orgenesis stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.